134 related articles for article (PubMed ID: 12748672)
1. B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation.
Bielorai B; Deeg HJ; Weintraub M; Neumann Y; Rosner E; Amariglio N; Rechavi G; Toren A
Bone Marrow Transplant; 2003 May; 31(10):931-4. PubMed ID: 12748672
[TBL] [Abstract][Full Text] [Related]
2. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
Eapen M; Rubinstein P; Zhang MJ; Camitta BM; Stevens C; Cairo MS; Davies SM; Doyle JJ; Kurtzberg J; Pulsipher MA; Ortega JJ; Scaradavou A; Horowitz MM; Wagner JE
J Clin Oncol; 2006 Jan; 24(1):145-51. PubMed ID: 16382124
[TBL] [Abstract][Full Text] [Related]
3. Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.
Ataergin S; Arpaci F; Cetin T; Guran S; Yakicier C; Beyzadeoglu M; Ozet A
Am J Hematol; 2006 May; 81(5):370-3. PubMed ID: 16628734
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia of donor origin after allogeneic bone marrow transplantation for precursor T-cell acute lymphoblastic leukemia: case report and review of the literature.
Reichard KK; Zhang QY; Sanchez L; Hozier J; Viswanatha D; Foucar K
Am J Hematol; 2006 Mar; 81(3):178-85. PubMed ID: 16493618
[TBL] [Abstract][Full Text] [Related]
5. Donor B cell lymphoma of the brain after allogeneic bone marrow transplantation for acute myeloid leukemia.
Verschuur A; Brousse N; Raynal B; Brison O; Rohrlich P; Rahimy C; Vilmer E
Bone Marrow Transplant; 1994 Sep; 14(3):467-70. PubMed ID: 7994275
[TBL] [Abstract][Full Text] [Related]
6. Recurrence of acute leukemia in donor cells after bone marrow transplantation: documentation by in situ DNA hybridization.
Mouratidou M; Sotiropoulos D; Deremitzaki K; Spathas DH; Hoffbrand AV; Prentice HG; Papanastasiou K; Tsakanikas S; Tsaftaridis P; Stamatelou M
Bone Marrow Transplant; 1993 Jul; 12(1):77-80. PubMed ID: 8374538
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy.
Yakoub-Agha I; Mesnil F; Kuentz M; Boiron JM; Ifrah N; Milpied N; Chehata S; Esperou H; Vernant JP; Michallet M; Buzyn A; Gratecos N; Cahn JY; Bourhis JH; Chir Z; Raffoux C; Socié G; Golmard JL; Jouet JP;
J Clin Oncol; 2006 Dec; 24(36):5695-702. PubMed ID: 17116940
[TBL] [Abstract][Full Text] [Related]
8. Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation.
Glasser L; Meloni-Ehrig A; Greaves W; Demel KC; Butera J
Transfusion; 2009 Mar; 49(3):555-62. PubMed ID: 19040490
[TBL] [Abstract][Full Text] [Related]
9. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
Takahashi R; Shimazaki C; Inaba T; Nakagawa M; Yamaoka M
Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation.
Gomyo H; Murayama T; Kizaki T; Mizuno I; Kitaori K; Sao H; Tobinai K; Koizumi K; Imoto S
Bone Marrow Transplant; 2000 Sep; 26(5):577-9. PubMed ID: 11019851
[TBL] [Abstract][Full Text] [Related]
11. Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
Eapen M; Giralt SA; Horowitz MM; Klein JP; Wagner JE; Zhang MJ; Tallman MS; Marks DI; Camitta BM; Champlin RE; Ringdén O; Bredeson CN; Martino R; Gale RP; Cairo MS; Litzow MR; deLima M
Bone Marrow Transplant; 2004 Oct; 34(8):721-7. PubMed ID: 15322568
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
13. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic marrow grafting using HL-A matched donor-recipient sibling pairs.
Thomas ED; Bryant JI; Buckner CD; Clift RA; Fefer A; Fialkow PJ; Funk DD; Neiman PE; Rudolph RH; Slichter SJ; Storb R
Trans Assoc Am Physicians; 1971; 84():248-61. PubMed ID: 4151544
[No Abstract] [Full Text] [Related]
15. Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor.
Orciuolo E; Azzarà A; Bandini G; Galimberti S; Bonifazi F; Fazzi R; Petrini M
Bone Marrow Transplant; 2004 Apr; 33(8):859-61. PubMed ID: 14743194
[TBL] [Abstract][Full Text] [Related]
16. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
Gopcsa L; Barta A; Banyai A; Konya M; Pajor L; Földi J; Paloczi K
Bone Marrow Transplant; 2002 Mar; 29(5):449-52. PubMed ID: 11919736
[TBL] [Abstract][Full Text] [Related]
17. Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia.
Moore J; Nivison-Smith I; Goh K; Ma D; Bradstock K; Szer J; Durrant S; Schwarer A; Bardy P; Herrmann R; Dodds A
Biol Blood Marrow Transplant; 2007 May; 13(5):601-7. PubMed ID: 17448920
[TBL] [Abstract][Full Text] [Related]
18. Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Schetelig J; Bornhäuser M; Schmid C; Hertenstein B; Schwerdtfeger R; Martin H; Stelljes M; Hegenbart U; Schäfer-Eckart K; Füssel M; Wiedemann B; Thiede C; Kienast J; Baurmann H; Ganser A; Kolb HJ; Ehninger G
J Clin Oncol; 2008 Nov; 26(32):5183-91. PubMed ID: 18768435
[TBL] [Abstract][Full Text] [Related]
19. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
[TBL] [Abstract][Full Text] [Related]
20. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
